Conatus Pharmaceuticals Inc.
Home
About
Management Team
Board of Directors
Careers
Industry
Programs
Emricasan
CTS-2090
Partnerships
Investors
News / Events
Company Info
Stock Data
SEC Filings
Governance
Contact
All SEC Filings
Investors
Investors
News / Events
Press Releases
Events
Email Alerts
Company Info
FAQ
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board Committees
Governance Documents
Investor Tools
Email Alerts
RSS News Feed
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-Q
3
4
4/A
424B4
424B5
5
8-A12B
8-K
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DRS
EFFECT
REGDEX
REGDEX/A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2019
2018
2017
2016
2015
2014
2013
2011
2010
2007
2006
Date
Form
Description
PDF
XBRL
Pages
02/10/17
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
EX-99
10
02/09/17
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
EX-99.A
20
02/07/17
4
Statement of changes in beneficial ownership of securities
1
02/07/17
3
Initial statement of beneficial ownership of securities
Documents
EX-24
4
02/07/17
8-K
Current report filing
3
02/02/17
4
Statement of changes in beneficial ownership of securities
1
02/02/17
3
Initial statement of beneficial ownership of securities
Documents
EX-24
4
02/01/17
4
Statement of changes in beneficial ownership of securities
1
02/01/17
4
Statement of changes in beneficial ownership of securities
1
02/01/17
4
Statement of changes in beneficial ownership of securities
1
7
8
9
10
11
12
13
14
15
16